Effects of Hypervapotron Geometry on Thermalhydraulic Performance von Youchison, D. L., Ulrickson, M. A., Bullock, J. H.

Volltext

A Comparison of Two-Phase Computational Fluid Dynamics Codes Applied to the ITER First Wall Hypervapotron von Youchison, Dennis L, Ulrickson, Michael A, Bullock, James H

Volltext

Effects of Hypervapotron Geometry on Thermalhydraulic Performance von Youchison, Dennis L., Ulrickson, Michael A., Bullock, James H.

Volltext

First Wall Qualification Testing at SNL von Tanaka, T.J., Ying, A., Narula, M., Ulrickson, M.A.

Volltext

Finite Element Stress Analysis OF ITER Module 13 von Garde, J., Youchison, D., Natoni, G., Bullock, J., Tanaka, T.J., Ulrickson, M.A., Narula, M., Ying, A., Sawan, M., Wilson, P.

Volltext

Plasma-surface interactions 16 von LIPSCHULTZ, Bruce, HAASZ, Anthony A, LABOMBARD, Brian, STANGEBY, Peter C, TERRY, James L, ULRICKSON, Michael A

Volltext

Multi-channel infrared thermometer von ULRICKSON, MICHAEL A

Volltext bestellen

Extreme-UV electrical discharge source von NYGREN RICHARD E, FORNACIARI NEAL R, ULRICKSON MICHAEL A

Volltext bestellen

Extreme-UV electrical discharge source von Fornaciari, Neal R, Nygren, Richard E, Ulrickson, Michael A

Volltext bestellen

Extreme-uv electrical discharge source von NEAL R. FORNACIARI, RICHARD E. NYGREN, MICHAEL A. ULRICKSON

Volltext bestellen

EXTREME-UV ELECTRICAL DISCHARGE SOURCE von FORNACIARI, NEAL, R, ULRICKSON, MICHAEL, A, NYGREN, RICHARD, E

Volltext bestellen

Axicabtagene ciloleucel as first-line therapy in high-risk large B-cell lymphoma: the phase 2 ZUMA-12 trial von Neelapu, Sattva S., Dickinson, Michael, Munoz, Javier, Ulrickson, Matthew L., Thieblemont, Catherine, Oluwole, Olalekan O., Herrera, Alex F., Ujjani, Chaitra S., Lin, Yi, Riedell, Peter A., Kekre, Natasha, de Vos, Sven, Lui, Christine, Milletti, Francesca, Dong, Jinghui, Xu, Hairong, Chavez, Julio C.

Volltext

Safety and Efficacy of Axicabtagene Ciloleucel versus Standard of Care in Patients 65 Years of Age or Older with Relapsed/Refractory Large B-Cell Lymphoma von Westin, Jason R, Locke, Frederick L, Dickinson, Michael, Ghobadi, Armin, Elsawy, Mahmoud, van Meerten, Tom, Miklos, David B, Ulrickson, Matthew L, Perales, Miguel-Angel, Farooq, Umar, Wannesson, Luciano, Leslie, Lori, Kersten, Marie José, Jacobson, Caron A, Pagel, John M, Wulf, Gerald, Johnston, Patrick, Rapoport, Aaron P, Du, Linqiu, Vardhanabhuti, Saran, Filosto, Simone, Shah, Jina, Snider, Julia T, Cheng, Paul, To, Christina, Oluwole, Olalekan O, Sureda, Anna

Volltext

Axicabtagene Ciloleucel as Second-Line Therapy for Large B-Cell Lymphoma von Locke, Frederick L, Miklos, David B, Jacobson, Caron A, Perales, Miguel-Angel, Kersten, Marie-José, Oluwole, Olalekan O, Ghobadi, Armin, Rapoport, Aaron P, McGuirk, Joseph, Pagel, John M, Muñoz, Javier, Farooq, Umar, van Meerten, Tom, Reagan, Patrick M, Sureda, Anna, Flinn, Ian W, Vandenberghe, Peter, Song, Kevin W, Dickinson, Michael, Minnema, Monique C, Riedell, Peter A, Leslie, Lori A, Chaganti, Sridhar, Yang, Yin, Filosto, Simone, Shah, Jina, Schupp, Marco, To, Christina, Cheng, Paul, Gordon, Leo I, Westin, Jason R

Volltext

Survival with Axicabtagene Ciloleucel in Large B-Cell Lymphoma von Westin, Jason R., Oluwole, Olalekan O., Kersten, Marie José, Miklos, David B., Perales, Miguel-Angel, Ghobadi, Armin, Rapoport, Aaron P., Sureda, Anna, Jacobson, Caron A., Farooq, Umar, van Meerten, Tom, Ulrickson, Matthew, Elsawy, Mahmoud, Leslie, Lori A., Chaganti, Sridhar, Dickinson, Michael, Dorritie, Kathleen, Reagan, Patrick M., McGuirk, Joseph, Song, Kevin W., Riedell, Peter A., Minnema, Monique C., Yang, Yin, Vardhanabhuti, Saran, Filosto, Simone, Cheng, Paul, Shahani, Shilpa A., Schupp, Marco, To, Christina, Locke, Frederick L.

Volltext

KITE-363: A phase 1 study of an autologous anti-CD19/CD20 chimeric antigen receptor (CAR) T-cell therapy in patients with relapsed/refractory (R/R) B-cell lymphoma (BCL) von Nastoupil, Loretta J., Dahiya, Saurabh, Miklos, David Bernard, Reagan, Patrick Michael, Ulrickson, Matthew, Jung, A. Scott, Kloos, Ioana, Dong, Jinghui, Chou, Justin, Murakami, Jodi, Rodriguez, Katherine, Nahas, Myrna

Volltext

Myeloid/lymphoid neoplasm with ZMYM2::FGFR1 rearrangement: A complex trilineage phenotypic and clonal evolution with associated genomic alterations von Chen, Dong, Liu, Guang, Lewis, Michael R., Li, Xia, Ulrickson, Matthew, Nath, Rajneesh, Chen, Weina

Volltext

3-Year Analysis of ZUMA-12: A Phase 2 Study of Axicabtagene Ciloleucel (Axi-Cel) As First-Line Therapy in Patients with High-Risk Large B-Cell Lymphoma (LBCL) von Chavez, Julio C., Dickinson, Michael, Munoz, Javier L., Ulrickson, Matthew L., Thieblemont, Catherine, Oluwole, Olalekan O., Herrera, Alex F., Ujjani, Chaitra S, Lin, Yi, Riedell, Peter A., Kekre, Natasha K., de Vos, Sven, Lui, Christine, Wulff, Jacob, Williams, Chad M., Peng, Weixin, Kloos, Ioana, Xu, Hairong, Neelapu, Sattva S.

Volltext

Primary overall survival analysis of the phase 3 randomized ZUMA-7 study of axicabtagene ciloleucel versus standard-of-care therapy in relapsed/refractory large B-cell lymphoma von Westin, Jason, Oluwole, Olalekan O., Kersten, Marie José, Miklos, David Bernard, Perales, Miguel-Angel, Ghobadi, Armin, Rapoport, Aaron, Sureda, Anna, Jacobson, Caron Alyce, Farooq, Umar, van Meerten, Tom, Ulrickson, Matthew L., Elsawy, Mahmoud, Leslie, Lori A., Chaganti, Sridhar, Dickinson, Michael, Yang, Yin, Schupp, Marco Andreas, To, Christina Ann, Locke, Frederick L.

Volltext

Clinical and patient (pt)-reported outcomes (PROs) in a phase 3, randomized, open-label study evaluating axicabtagene ciloleucel (axi-cel) versus standard-of-care (SOC) therapy in... von Westin, Jason, Locke, Frederick L., Dickinson, Michael, Ghobadi, Armin, Elsawy, Mahmoud, van Meerten, Tom, Miklos, David Bernard, Ulrickson, Matthew, Perales, Miguel-Angel, Farooq, Umar, Wannesson, Luciano, Leslie, Lori Ann, Kersten, Marie José, Jacobson, Caron Alyce, Pagel, John M., Wulf, Gerald, Du, Linqiu, Snider, Julia, To, Christina Ann, Oluwole, Olalekan O.

Volltext